focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,748.50
Bid: 2,175.00
Ask: 1,450.00
Change: -64.00 (-3.53%)
Spread: -725.00 (-33.333%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,812.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Amazon and Nestle join public-private plan to save world's forests

Thu, 22nd Apr 2021 15:30

* LEAF coalition aims to raise an initial $1 bln

* Calls for countries to apply by July

* Payouts linked to emissions between 2022-2026

By Simon Jessop

LONDON, April 22 (Reuters) - The United States, Norway and
Britain joined forces with companies including Amazon
and Nestle on Thursday to launch a project aimed at
protecting the world's tropical forests.

Announcing the Lowering Emissions by Accelerating Forest
finance (LEAF) Coalition at the U.S.-convened Leaders Summit on
climate, the public-private project aims to raise at least $1
billion in initial financing, it said.

Governments and companies taking part will pay countries
with tropical and subtropical forests for emissions reductions,
a move it hopes will help reduce and eventually end
deforestation.

As the world looks to move quickly to a low-carbon economy
to prevent catastrophic climate change, protecting the forests
that help remove carbon from the atmosphere naturally is seen as
a crucial step, but one that has so far largely failed.

The pace of deforestation actually picked up in 2020, LEAF
said, with data from Global Forest Watch showing a 12 percent
increase from the prior year or more than 10 million hectares of
primary tropical forest, roughly the size of Switzerland.

"The LEAF coalition is a groundbreaking example of the scale
and type of collaboration that is needed to fight the climate
crisis and achieve net-zero emissions globally by 2050," said
U.S. Special Presidential Envoy for Climate John Kerry.

"Bringing together government and private-sector resources
is a necessary step in supporting the large-scale efforts that
must be mobilized to halt deforestation and begin to restore
tropical and subtropical forests."

Countries looking to take part in the programme will need to
have the reduction in deforestation-linked emissions verified by
a new, more rigorous standard assessed at the national level by
an independent third party, the coalition said in a statement.

With applications due by July 2021 and the aim of signing
contracts before the end of the year, payments would be based on
emissions reductions linked to reducing levels of deforestation
or degradation, or by restoring forests, between 2022 and 2026.

Companies looking to take part in the project will only be
allowed to join if they can show a commitment to "deep voluntary
cuts" in their own emissions, in line with science-based targets
and the Paris Agreement on climate.

"Climate change is the greatest threat to our planet, and
the LEAF coalition offers us an opportunity to bring together
governments and companies to fight it," said Jeff Bezos, Amazon
founder and CEO.

"In uniting behind a common cause, the countries and
companies of the coalition have a chance to end deforestation by
2030."

Among other companies to sign up to the project are Airbnb
, Boston Consulting Group, GlaxoSmithKline,
McKinsey, Salesforce, Bayer and Unilever
, although more are expected to join over time.

U.S. non-profit Emergent will oversee the administration of
the project.
(Reporting by Simon Jessop; Editing by Nick Macfie)

More News
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.